Skip to main content

Table 2 Worst grade of adverse events observed during chemotherapy at phase I dose

From: Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604

 

LEVEL 1 n = 6

LEVEL 2 n = 6

Grade (NCI-CTC ver. 3.0)

Toxicity

1–2

3

4

1–2

3

4

Leukocytes

5

1

0

5

1

0

Neutrophils

4

2

0

3

2

1

Hemoglobin

5

1

0

5

1

0

Platelets

6

0

0

4

0

2*

Fatigue

6

0

0

6

0

0

Anorexia

6

0

0

6

0

0

Nausea

6

0

0

6

0

0

Vomiting

6

0

0

6

0

0

Esophagitis

0

0

0

0

0

0

Diarrhea

6

0

0

6

0

0

Constipation

6

0

0

6

0

0

Alopecia

6

0

0

6

0

0

FN

6

0

0

6

0

0

Pheumonitis

6

0

0

6

0

0

Hypertension

5

1*

0

6

0

0

Glaucoma

6

0

0

5

1*

0

  1. NCI-CTC National Cancer Institute - Common Toxicity Criteria
  2. FN Febrile Neutropenia
  3. Asterisk: dose limiting toxicity